Guidelines for breast cancer surveillance for women not eligible for population screening, by individual risk assessment;Screening op mammacarcinoom buiten het landelijke bevolkingsonderzoek, op grond van individuele risico-inschatting

Nederlands Tijdschrift voor Geneeskunde

Volumn 145, Issue 3, 2001, Pages 120-125

  Van Asperen, C J ^a   De Bock, G H ^a   Van der Horst, F ^a   De Koning, H J ^a   Rutgers, E J Th ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AWARENESS; BREAST CANCER; BREAST EXAMINATION; CANCER SCREENING; EARLY DIAGNOSIS; FAMILY HISTORY; FEMALE; GENETIC RISK; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; RECOGNITION; REVIEW; RISK ASSESSMENT;

ADULT; BREAST NEOPLASMS; BREAST SELF-EXAMINATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NETHERLANDS; PRACTICE GUIDELINES; RISK ASSESSMENT; ULTRASONOGRAPHY;

EID: 0035915680     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. CBO-richtlijn 'Mammacarcinoom: Screening en diagnostiek'
2. Breast cancer (1)
3. History of breast-feeding in relation to breast cancer risk: A review of the epidemiologic literature
4. Oral contraceptives and risk of breast cancer in women aged 20-54 years
5. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood
6. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction
7. 2 genes in breast cancer families. The Breast Cancer Linkage Consortium
8. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors
9. Breast cancer screening with mammography: Overview of Swedish randomised trials
10. 16-Year mortality from breast cancer in the UK trial of early detection of breast cancer
11. Positive predictive value of screening mammography by age and family history of breast cancer
12. The impact of a breast cancer screening programme on quality-adjusted life-years
13. Radiation risk of mammography related to benefit in screening programmes: A favourable balance?
14. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study
15. Breast cancer screening for women 40-49
16. Ten-year risk of false positive screening mammograms and clinical breast examinations
17. The breast cancer screening controversy and the National Institutes of Health consensus development conference on breast cancer screening for women ages 40-49
18. Breast screening in women aged 40-49 years: What next?
19. In search of the best upper age limit for breast cancer screening
20. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians
21. The assessment of genetic risk of breast cancer: A set of GP guidelines
22. Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics
23. The British Association of Surgical Oncology guidelines for surgeons in the management of symptomatic breast disease in the UK (998 revision)
24. Genetics, biomarkers, and control of breast cancer: A review
25. Periodiek onderzoek van families met een erfelijke predispositie voor mammacarcinoom
26. Vrouwen met erfelijk risico op borstkanker: Consensus van chirurgische vertegenwoordigers van de werkgroepen voor erfelijke tumoren ten aanzien van intensieve controle, diagnostiek en preventieve ablatio
27. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: Review of 183,134 screening mammograms in Albuquerque, New Mexico
28. Screening mammography: Sensitivity and specificity in relation to hormone repacement therapy
29. The role of breast self-examination in early breast cancer detection (results of the 5-years USSR/WHO randomized study in Leningrad)
30. Randomized trial of breast self-examination in Shanghai: Methodology and preliminary results
31. Survival of women ages 40-49 years with breast carcinoma according to method of detection
32. Influence of delay on survival in patients with breast cancer: A systematic review
33. Breast cancer detection and death rates among women aged 40 to 49 years
34. Breast cancer detection and death rates among women aged 50 to 59 years
35. Breast cancer after a negative screen: Follow-up of women participating in the DOM Screening Programme
36. Age-dependent growth rate of primary breast cancer
37. Breast cancer: Age-specific growth rates and screening strategies
38. Increased benefit from shorter screening mammography intervals for women ages 40-49 years
39. Mammography in women under age 30: Is there clinical benefit?
40. Breast cancers in women 35 years of age and younger: Mammographic findings
41. Occult cancer in women with dense breasts: Detection with screening US-diagnostic yield and tumor characteristics
42. Breast MR imaging screening in I92 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results